Risk Factors Identified for Repeat COVID-19 in Patients With Systemic Autoimmune Rheumatic Diseases
Jeffrey Sparks, MD, MMSc, and colleagues recently completed the first study of risk factors for repeat COVID-19 in an immunocompromised population. They report that use of rituximab, use of methotrexate, and younger age increased the risk of repeat COVID-19 among patients with systemic autoimmune rheumatic diseases.
Read More...